OCT 26, 2026 · JOURNAL ARTICLE
Patient Acceptance of Semi-Inpatient Radioligand Therapy: Insights from a Prospective Survey in Nuclear Medicine
Nuklearmedizin - Nuclearmedicine
Abstract Radioligand therapy with lutetium-177 is an effective treatment option for patients with metastatic castration-resistant prostate cancer and metastatic neuroendocrine tumo